Chen Zhaoshi, director of the Hong Kong Food and Health Bureau, said that the authorities have reached a preliminary agreement with the three coronary virus vaccine manufacturers. Except for the 1 million dose of vaccines of Kexing Bio, they arrived in Hong Kong next month, and they were introduced by Mainland Fujun Pharmaceutical. GermanyThe vaccine cooperated with Biontech and Pfizer can also be delivered in the first quarter.As for the vaccine developed by Astraikon with Oxford University, it is expected that it will be batch in Hong Kong next year.
According to Radio Hong Kong, Chen Zhaoshi stated in a program that it will only be purchased after ensuring the safety of the vaccine, the guarantee and effectiveness of the quality, and the authorities have launched an emergency legislative work to deal with the vaccine registration problem in Hong Kong.The preparation of injection will be vaccinated as soon as possible.
As for the priority groups of medical staff, members of the hospital, and employees, elders, and patients with long -term diseases, which type of priority group will be vaccinated first.The final dose of Hong Kong and which vaccine it is.She given the Biontech vaccine to refrigerate at -70 degrees. It requires more central coordination. The transportation time is more accurate.
Chen Zhaoshi said that in terms of the elders, the number of people over 60 years old is more than 1.8 million. The authorities have initially conceived the older first injections and then pushed them one by one.?
?
